[Possibilities of adoptive immunochemotherapy in the treatment of non-small-cell lung cancer].
Davydov
M I
MI
Normantovich
V A
VA
Polotskiĭ
B E
BE
Ivshina
A V
AV
Mkheidze
D M
DM
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D016219:Immunotherapy, Adoptive; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D016685:Mitomycin / Q000627:therapeutic use; D013902:Radiography, Thoracic; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D016685:Mitomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Vozmozhnosti adoptivnoĭ immunokhimioterapii v lechenii nemelkokletochnogo raka legkogo.